Literature DB >> 17170450

Alpha2,6-linked sialic acid acts as a receptor for Feline calicivirus.

Amanda D Stuart1, T David K Brown.   

Abstract

Feline calicivirus (FCV) is a major causative agent of respiratory disease in cats. It is also one of the few cultivatable members of the family Caliciviridae. It has recently been reported that FCV binding is in part due to interaction with junction adhesion molecule-A. This report describes the characterization of additional receptor components for FCV. Chemical treatment of cells with sodium periodate showed that FCV recognized carbohydrate moieties on the surface of permissive cells. Enzymic treatment with Vibrio cholerae neuraminidase demonstrated that sialic acid was a major determinant of virus binding. Further characterization using linkage-specific lectins from Maackia amurensis and Sambucus nigra revealed that FCV recognized sialic acid with an alpha2,6 linkage. Using various proteases and metabolic inhibitors, it was shown that alpha2,6-linked sialic acid recognized by FCV is present on an N-linked glycoprotein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17170450     DOI: 10.1099/vir.0.82158-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  54 in total

1.  Conformational changes in the capsid of a calicivirus upon interaction with its functional receptor.

Authors:  Robert J Ossiboff; Yi Zhou; Patrick J Lightfoot; B V Venkataram Prasad; John S L Parker
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

2.  Host-Specific Glycans Are Correlated with Susceptibility to Infection by Lagoviruses, but Not with Their Virulence.

Authors:  Ana M Lopes; Adrien Breiman; Mónica Lora; Béatrice Le Moullac-Vaidye; Oxana Galanina; Kristina Nyström; Stephane Marchandeau; Ghislaine Le Gall-Reculé; Tanja Strive; Aleksija Neimanis; Nicolai V Bovin; Nathalie Ruvoën-Clouet; Pedro J Esteves; Joana Abrantes; Jacques Le Pendu
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

3.  Tulane virus recognizes the A type 3 and B histo-blood group antigens.

Authors:  Dongsheng Zhang; Pengwei Huang; Lu Zou; Todd L Lowary; Ming Tan; Xi Jiang
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

4.  The Coxsackievirus and Adenovirus Receptor, a Required Host Factor for Recovirus Infection, Is a Putative Enteric Calicivirus Receptor.

Authors:  Tibor Farkas; Kui Yang; Jacques Le Pendu; Joel D Baines; Rhonda D Cardin
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

5.  Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner.

Authors:  Pengwei Huang; Ming Xia; Ming Tan; Weiming Zhong; Chao Wei; Leyi Wang; Ardythe Morrow; Xi Jiang
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

6.  Norovirus-host interaction: multi-selections by human histo-blood group antigens.

Authors:  Ming Tan; Xi Jiang
Journal:  Trends Microbiol       Date:  2011-06-24       Impact factor: 17.079

7.  Characterization of a Vesivirus Associated with an Outbreak of Acute Hemorrhagic Gastroenteritis in Domestic Dogs.

Authors:  Randall W Renshaw; Jennifer Griffing; Jaime Weisman; Lisa M Crofton; Melissa A Laverack; Robert P Poston; Gerald E Duhamel; Edward J Dubovi
Journal:  J Clin Microbiol       Date:  2018-04-25       Impact factor: 5.948

Review 8.  Norovirus immunology: Of mice and mechanisms.

Authors:  Kira L Newman; Juan S Leon
Journal:  Eur J Immunol       Date:  2015-08-25       Impact factor: 5.532

9.  Identification of regions and residues in feline junctional adhesion molecule required for feline calicivirus binding and infection.

Authors:  Robert J Ossiboff; John S L Parker
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

10.  Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution.

Authors:  Ming Tan; Ming Xia; Yutao Chen; Weiming Bu; Rashmi S Hegde; Jarek Meller; Xuemei Li; Xi Jiang
Journal:  PLoS One       Date:  2009-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.